Literature DB >> 29365295

Amyloid-Beta Solubility in the Treatment of Alzheimer's Disease.

M Paul Murphy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29365295     DOI： 10.1056/NEJMe1714638

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Everything but amyloid: new thinking prompts FDA revamp.

Authors:  Eva von Schaper
Journal:  Nat Biotechnol       Date:  2018-06-06       Impact factor: 54.908

Review 2.  Treating Alzheimer's disease by targeting iron.

Authors:  Sara Nikseresht; Ashley I Bush; Scott Ayton
Journal:  Br J Pharmacol       Date:  2019-02-11       Impact factor: 8.739

3.  Oligomeric Aβ in the monkey brain impacts synaptic integrity and induces accelerated cortical aging.

Authors:  Danielle Beckman; Sean Ott; Kristine Donis-Cox; William G Janssen; Eliza Bliss-Moreau; Peter H Rudebeck; Mark G Baxter; John H Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 4.  Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease.

Authors:  Robert I Richards; Sarah A Robertson; Daniel L Kastner
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

5.  Evidence of demyelination in mild cognitive impairment and dementia using a direct and specific magnetic resonance imaging measure of myelin content.

Authors:  Mustapha Bouhrara; David A Reiter; Christopher M Bergeron; Linda M Zukley; Luigi Ferrucci; Susan M Resnick; Richard G Spencer
Journal:  Alzheimers Dement       Date:  2018-04-19       Impact factor: 21.566

Review 6.  Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine.

Authors:  Aseel Eid; Isha Mhatre; Jason R Richardson
Journal:  Pharmacol Ther       Date:  2019-03-12       Impact factor: 12.310

7.  An Adequate Supply of Bis(ethylmaltolato)oxidovanadium(IV) Remarkably Reversed the Pathological Hallmarks of Alzheimer's Disease in Triple-Transgenic Middle-Aged Mice.

Authors:  Zhijun He; Lin Zheng; Xu Zhao; Xiaoqian Li; Hua Xue; Qionghui Zhao; Bingyu Ren; Nan Li; Jiazuan Ni; Yan Zhang; Qiong Liu
Journal:  Biol Trace Elem Res       Date:  2022-01-15       Impact factor: 3.738

Review 8.  Antisense Oligonucleotide Therapies for Neurodegenerative Diseases.

Authors:  C Frank Bennett; Adrian R Krainer; Don W Cleveland
Journal:  Annu Rev Neurosci       Date:  2019-07-08       Impact factor: 12.449

9.  Effects of Phenylethanoid Glycosides Extracted from Herba Cistanches on the Learning and Memory of the APP/PSI Transgenic Mice with Alzheimer's Disease.

Authors:  Jianhua Yang; Bowei Ju; Junping Hu
Journal:  Biomed Res Int       Date:  2021-01-18       Impact factor: 3.411

Review 10.  The essential elements of Alzheimer's disease.

Authors:  Peng Lei; Scott Ayton; Ashley I Bush
Journal:  J Biol Chem       Date:  2020-11-27       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.